Stock listing

BMV:LABB Genomma Lab Internacional SAB de CV Acciones

Home listing (BMV) of Genomma Lab Internacional SAB de CV

Follow Genomma Lab Internacional SAB de CV into a list and get an email when it puts out news.

Share price · BMV:LAB/B

$14.46 MXN -0.69 (-4.6%)

Close on Nov 20, 2026

Past year -17.8% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$14.41 – $14.88 MXNNov 20, 2026
Volume
3.16M sharesNov 20, 2026
Market cap
$14.14B MXNAt the close on Nov 20, 2026 · price × 977.8M shares outstanding
52-week range
$12.22 – $19.48 MXNLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$54.47M MXNMedian day 3.63M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Genomma Lab Internacional SAB de CV logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
OTC:GNMLF$0.85 USD+0.015 (+1.8%)150$0.85$0.85$0.85$0.835Close on Nov 10, 2026
Frankfurt:GEKA€0.724 EUR+0.025 (+3.6%)—€0.724€0.724€0.724€0.699Close on Nov 5, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · BMV:LAB/B · MXN, adjusted for splits

DayCloseChange%OpenHighLowVolume
$14.46-0.69-4.6%$14.61$14.88$14.413,162,570
$15.15-0.02-0.1%$15.23$15.52$15.003,821,335
$15.17-0.14-0.9%$15.38$15.38$15.103,613,633
$15.31-0.33-2.1%$15.64$15.70$15.252,985,853
$15.64+0.01+0.1%$15.58$15.79$15.532,990,605
$15.63+0.13+0.8%$15.57$15.78$15.483,774,586
$15.50-0.26-1.6%$15.56$15.85$15.453,648,665
$15.76-0.18-1.1%$15.86$16.15$15.643,517,913
$15.94+0.84+5.6%$15.17$16.00$15.123,718,002
$15.10-0.39-2.5%$15.45$15.53$14.804,758,769
$15.49+0.38+2.5%$15.19$15.62$15.112,851,420
$15.11-0.03-0.2%$15.06$15.63$14.934,349,870
$15.14+0.23+1.5%$14.60$15.19$14.603,639,970
$14.91+0.42+2.9%$14.54$14.97$14.483,340,451
$14.49-0.93-6.0%$15.34$15.34$14.344,343,601
$15.42-0.24-1.5%$15.62$15.75$15.2612,642,171
$15.66+0.33+2.2%$15.40$15.70$15.203,725,217
$15.33+0.65+4.4%$14.66$15.46$14.614,189,281
$14.68+0.30+2.1%$14.15$14.72$14.153,063,954
$14.38+0.11+0.8%$14.34$14.49$14.124,294,836
$14.27-0.12-0.8%$14.39$14.44$14.163,194,214
$14.39+0.20+1.4%$14.20$14.48$14.193,684,005
$14.19+0.40+2.9%$13.77$14.30$13.774,586,934
$13.790.000.0%$13.88$14.00$13.623,547,733
$13.79+0.49+3.7%$13.31$13.85$13.246,402,715
$13.30+0.18+1.4%$13.02$13.40$13.005,634,980
$13.12+0.06+0.5%$13.07$13.28$13.043,424,182
$13.06+0.24+1.9%$12.87$13.10$12.764,308,452
$12.82-0.01-0.1%$12.79$12.88$12.703,746,885
$12.83-0.02-0.2%$12.82$12.86$12.653,631,190
$12.85+0.33+2.6%$12.55$12.93$12.534,937,813
$12.52-0.31-2.4%$12.83$12.86$12.433,630,384
$12.83+0.27+2.1%$12.50$12.86$12.425,466,290
$12.56+0.05+0.4%$12.70$12.75$12.413,187,582
$12.51-0.28-2.2%$12.85$12.85$12.375,084,825
$12.79-0.15-1.2%$12.99$13.05$12.722,930,029
$12.94+0.10+0.8%$12.85$12.98$12.773,060,236
$12.84+0.01+0.1%$12.92$12.94$12.703,202,366
$12.83+0.22+1.7%$12.50$12.88$12.504,197,147
$12.61+0.10+0.8%$12.59$12.71$12.462,853,396
$12.51+0.19+1.5%$12.40$12.62$12.362,718,646
$12.32-0.04-0.3%$12.45$12.46$12.226,062,067
$12.36-0.24-1.9%$12.63$12.64$12.345,258,976
$12.60+0.28+2.3%$12.35$12.62$12.254,195,163
$12.32-0.28-2.2%$12.56$12.63$12.253,334,971
$12.60-0.07-0.6%$12.64$12.71$12.523,458,226
$12.67-0.07-0.5%$12.77$12.84$12.602,229,288
$12.74-0.17-1.3%$12.93$12.99$12.703,889,482
$12.91+0.10+0.8%$12.84$12.98$12.613,433,300
$12.81-0.41-3.1%$13.21$13.21$12.713,611,240
$13.22+0.18+1.4%$13.16$13.28$12.80854,873
$13.04-0.01-0.1%$13.10$13.26$12.986,209,728
$13.05+0.16+1.2%$12.88$13.21$12.837,861,880
$12.89-0.25-1.9%$13.15$13.15$12.813,449,492
$13.14-0.03-0.2%$13.20$13.39$13.113,475,494
$13.17-0.30-2.2%$13.43$13.48$13.125,486,099
$13.47-0.08-0.6%$13.47$13.67$13.382,514,653
$13.550.000.0%$13.54$13.70$13.303,097,503
$13.55+0.01+0.1%$13.54$13.74$13.483,357,937
$13.54-0.01-0.1%$13.52$13.65$13.362,365,654
$13.55-0.02-0.1%$13.50$13.72$13.492,286,615
$13.57+0.30+2.3%$13.35$13.64$13.303,072,467
$13.27-0.16-1.2%$13.46$13.71$13.253,865,306

Splits

1 split · BMV:LAB/B · every price before a split is adjusted for it

DayRatioWhat
2-for-1Split
Ticker
BMV:LAB/B
Asset type
Stock
Sector
Health care
Industry
Pharmaceuticals
Exchange
BMV
Currency
MXN

What changed lately

Latest news

All Genomma Lab Internacional SAB de CV news

Genomma Lab Internacional SAB de CV on 6ix

Sector
Health care
Industry
Pharmaceuticals
News releases
2 in the last 12 months · 8 in all · newest Apr 23, 2026 · oldest 2024
Calls
19 calls with a replay · 19 with a transcript · latest Jul 23, 2026
Decks
29 decks · latest Apr 1, 2026

Where Genomma Lab Internacional SAB de CV is listed

ListingExchangeCountryCurrency
BMV:LABB · Home listing · This pageBMVMexicoMXN
BIVA:LABBBIVAMexicoMXN
LS Exchange:A0Q4TCLS ExchangeGermanyEUR
Lang & Schwarz:A0Q4TCLang & SchwarzGermanyEUR
OTC:GNMLFOTCUnited StatesUSD
Dusseldorf:GEKADusseldorfGermanyEUR
Frankfurt:GEKAFrankfurtGermanyEUR

Valuation

P/E 8.3× against a median of 28.6×: 2nd lowest of 7 Pharmaceuticals companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$18.20B MXN
P/E
8.3×
EV/sales
1.1×
EV/EBITDA
4.8×
Price/book
1.2×
Gross margin
62.6%
Operating margin
20.3%
Net margin
10.0%
Debt to equity
0.6×
Beta
No index for this market yet

Pharmaceuticals: the 10 companies nearest in size, of 492 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Genomma Lab Internacional SAB de CV Class B · BMV:LAB/BUS$740.5MUS$953.0M8.3×1.1×4.8×1.2×10.0%0.6×n/a
Dezhan Healthcare Co., Ltd. Class A · SZSE:000813US$768.0MUS$680.7Mn/a13.0×n/a1.1×−111.1%0.0×n/a
Knight Therapeutics, Inc. · TSX:GUDUS$763.1MUS$683.3M68.5×1.7×10.5×1.4×2.8%0.0×0.33
Guizhou Bailing Group Pharmaceutical Co., Ltd. Class A · SZSE:002424US$757.0MUS$728.7Mn/a2.1×n/a1.6×−5.5%0.0×n/a
Luye Pharma Group Ltd. · HKEX:2186US$751.7MUS$1.02B8.1×1.1×3.3×0.3×9.8%0.8×n/a
Ardelyx, Inc. · NASDAQ:ARDXUS$751.6MUS$718.6Mn/a1.5×n/a4.6×−11.8%1.5×0.88
Bliss GVS Pharma Limited · NSE:BLISSGVSUS$735.1MUS$716.7M42.3×6.2×28.1×5.3×15.0%0.0×n/a
Hunan Fangsheng Pharmaceutical Co., Ltd. Class A · SSE:603998US$732.2MUS$694.9M14.9×2.5×n/a2.7×17.4%0.0×n/a
Wanbangde Pharmaceutical Holding Group Co., Ltd. Class A · SZSE:002082US$729.9MUS$658.8Mn/a5.0×n/a1.9×−20.2%0.1×n/a
Zhuzhou Qianjin Pharmaceutical Co., Ltd. Class A · SSE:600479US$718.1MUS$612.0M13.4×1.1×n/a1.5×9.5%0.0×n/a
Chongqing Pharscin Pharmaceutical Co., Ltd. Class A · SZSE:002907US$708.3MUS$620.6M50.3×4.9×n/a2.7×11.0%0.0×n/a
Median of the othersUS$743.3MUS$689.1M28.6×2.3×10.5×1.8×6.2%0.0×0.61

Forecasts

Analysts' consensus from EODHD, read Nov 16, 2026. Not 6ix's view and not investment advice.

Price target
21.33 MXN · Analysts' mean
EPS, year to Dec 2026
1.86 · 5 analysts
Revenue, year to Dec 2026
17.81B · 6 analysts

Events

Next results
Feb 24, 2027 (expected)

Calls

CallWhenStatus
Genomma Lab Internacional SAB de CV (BMV:LAB/B) Q2 2026 Earnings CallThu, Jul 23, 2026 · 1:00 PM ETReplay
Genomma Lab Internacional SAB de CV (BMV:LAB/B) Q1 2026 Earnings CallThu, Apr 23, 2026 · 1:00 PM ETReplay
Genomma Lab Internacional SAB de CV (BMV:LAB/B) Q1 2025 Earnings CallFri, May 02, 2025 · 1:00 PM ETReplay
Genomma Lab Internacional SAB de CV (BMV:LAB/B) Q4 2024 Earnings CallThu, Feb 27, 2025 · 12:00 PM ETReplay
Genomma Lab Internacional SAB de CV (BMV:LAB/B) Q3 2024 Earnings CallThu, Oct 24, 2024 · 1:00 PM ETReplay
Genomma Lab Internacional SAB de CV (BMV:LAB/B) Q2 2024 Earnings CallThu, Jul 25, 2024 · 1:00 PM ETReplay
Genomma Lab Internacional SAB de CV (BMV:LAB/B) Q1 2024 Earnings CallThu, Apr 25, 2024 · 1:00 PM ETReplay
Genomma Lab Internacional SAB de CV (BMV:LAB/B) Q4 2023 Earnings CallThu, Feb 22, 2024 · 12:00 PM ETReplay
Genomma Lab Internacional SAB de CV (BMV:LAB/B) Q3 2023 Earnings CallThu, Oct 26, 2023 · 1:00 PM ETReplay
Genomma Lab Internacional SAB de CV (BMV:LAB/B) Q2 2023 Earnings CallThu, Jul 27, 2023 · 1:00 PM ETReplay
All 19 calls
CallWhenStatus
Genomma Lab Internacional SAB de CV (BMV:LAB/B) Q1 2023 Earnings CallThu, Apr 27, 2023 · 11:00 AM ETReplay
Genomma Lab Internacional SAB de CV (BMV:LAB/B) Q4 2022 Earnings CallThu, Feb 23, 2023 · 11:00 AM ETReplay
Genomma Lab Internacional SAB de CV (BMV:LAB/B) Q3 2022 Earnings CallThu, Oct 27, 2022 · 11:00 AM ETReplay
Genomma Lab Internacional SAB de CV (BMV:LAB/B) Q2 2022 Earnings CallThu, Jul 28, 2022 · 11:00 AM ETReplay
Genomma Lab Internacional SAB de CV (BMV:LAB/B) Q1 2022 Earnings CallThu, Apr 28, 2022 · 11:00 AM ETReplay
Genomma Lab Internacional SAB de CV (BMV:LAB/B) Q4 2021 Earnings CallThu, Feb 24, 2022 · 11:00 AM ETReplay
Genomma Lab Internacional SAB de CV (BMV:LAB/B) Q3 2021 Earnings CallWed, Oct 27, 2021 · 11:00 PM ETReplay
Genomma Lab Internacional SAB de CV (BMV:LAB/B) Q2 2021 Earnings CallWed, Jul 28, 2021 · 11:00 AM ETReplay
Genomma Lab Internacional SAB de CV (BMV:LAB/B) Q1 2021 Earnings CallTue, Apr 13, 2021 · 11:00 AM ETReplay

Results days

QuarterResultsShare move
Q3 2026Oct 21, 2026 · After close+2.1%
Q2 2026Jul 22, 2026 · After close−3.5%
Q1 2026Apr 22, 2026 · After close−6.5%
Q4 2025Feb 25, 2026 · After close+2.2%
Q3 2025Oct 22, 2025 · After close+1.3%
Q2 2025Jul 23, 2025 · After close−1.2%
Q1 2025Apr 30, 2025 · Before open−6.8%
Q4 2024Feb 19, 2025 · After close−1.9%
Q3 2024Oct 23, 2024 · Before open+0.3%
Q2 2024Jul 24, 2024 · Before open−1.4%
All 20 quarters
QuarterResultsShare move
Q1 2024Apr 24, 2024 · After close+7.9%
Q4 2023Feb 21, 2024 · After close+10.1%
Q3 2023Oct 25, 2023 · After close+2.6%
Q2 2023Jul 26, 2023 · After close+4.1%
Q1 2023Apr 26, 2023 · After close+0.6%
Q4 2022Feb 22, 2023 · After close−10.0%
Q3 2022Oct 26, 2022 · After close+3.7%
Q2 2022Jul 27, 2022 · After close−0.4%
Q1 2022Apr 27, 2022 · After close−1.2%
Q4 2021Feb 23, 2022 · After close−1.0%

Open Events

Decks

DeckKindSlidesDate
Q3 2026 Earnings PresentationEarnings27 slidesApr 1, 2026
Q2 2026 Earnings PresentationEarnings29 slidesApr 1, 2026
Investor Presentation (December 2025)Investor deck32 slidesDecember 2025
Q3 2025 Earnings PresentationEarnings26 slidesOctober 2025
Q2 2025 Earnings PresentationEarnings33 slidesJuly 2025
Genomma Lab Intl Sab Ord — Q1 2025 Earnings PresentationEarnings58 slidesMay 2, 2025
Q4 2024 Earnings PresentationEarnings64 slidesMarch 2025
Investor Presentation (May 2024)Investor deck100 slidesMay 2024
Investor Presentation (February 2024)Investor deck100 slidesFebruary 2024
Investor Presentation (August 2023)Investor deck93 slidesAugust 2023
All 29 decks
DeckKindSlidesDate
Investor Presentation (May 2023)Investor deck92 slidesMay 2023
Investor Presentation (January 2023)Investor deck62 slidesJanuary 2023
Investor Presentation (July 2022)Investor deck51 slidesJuly 2022
Investor Presentation (May 2022)Investor deck49 slidesMay 2022
Investor Presentation (September 2021)Investor deck66 slidesSeptember 2021
Investor Presentation (May 2021)Investor deck60 slidesMay 2021
Investor Presentation (September 2020)Investor deck46 slidesSeptember 2020
Investor Presentation (March 2020)Investor deck50 slidesMarch 2020
Investor Presentation (November 2019)Investor deck52 slidesNovember 2019
Investor Day (November 2016)Investor day55 slidesNov 3, 2016
Investor Day (November 2016)Investor day55 slidesNov 3, 2016
Investor Presentation (June 2016)Investor deck22 slidesJune 2016
Investor Day (September 2015)Investor day58 slidesSep 29, 2015
Investor Day (September 2015)Investor day58 slidesSep 29, 2015
Investor Presentation (September 2015)Investor deck30 slidesSeptember 2015
Investor Day (November 2014)Investor day77 slidesNov 7, 2014
Investor Presentation (November 2014)Investor deck26 slidesNovember 2014
Investor Presentation (November 2014)Investor deck26 slidesNovember 2014
Proxy Contest (April 2012)Proxy contest26 slidesApr 26, 2012

Open Decks

Financials

Annual, in MXN

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue17.5B18.6B16.5B16.8B15.5B13.9B12.7B11.8B12.1B11.3B
Cost of revenue6.52B6.68B6.38B6.66B5.92B5.28B4.61B4.03B3.96B3.64B
Gross profit11.0B11.9B10.1B10.2B9.56B8.59B8.10B7.76B8.12B7.68B
Selling, general and administrative7.29B8.06B6.89B6.92B6.57B5.67B5.82B5.58B5.62B7.49B
Operating income3.76B3.91B3.20B3.24B2.99B2.92B2.27B2.19B2.50B286.6M
Depreciation and amortization379.1M359.6M246.4M227.1M170.3M159.0M142.2M81.2M69.8M83.8M
EBITDA4.14B4.27B3.45B3.47B3.16B3.08B2.42B2.27B2.57B370.4M
Interest expense796.7M887.8M829.9M525.6M444.4M461.1M606.7M554.6M00
Income before tax2.43B2.89B1.72B2.26B2.22B2.24B1.56B1.76B2.17B-1.52B
Income tax867.6M914.0M766.8M795.7M654.0M758.7M126.5M
Net income1.61B1.49B1.03B1.39B1.31B1.47B764.5M1.11B1.28B-1.68B
Earnings per share, basic1.651.581.081.441.301.440.751.091.22

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents3.07B2.38B1.47B1.50B1.22B2.05B899.7M1.39B1.07B1.85B
Short-term investments213.6M89.2M183.2M205.9M23.2M
Receivables4.50B4.44B3.71B4.27B4.23B4.03B6.31B5.32B5.01B4.36B
Inventory1.84B2.18B1.91B2.40B2.09B1.94B1.91B1.70B1.26B1.17B
Current assets12.8B12.4B10.6B11.3B11.5B12.0B9.82B9.00B7.84B7.80B
Property, plant and equipment3.59B3.37B2.85B2.22B1.87B548.6M412.8M
Goodwill45.8M90.8M90.8M78.8M52.4M52.0M
Total assets23.8B24.1B20.7B21.6B21.5B22.1B19.3B18.1B15.9B15.7B
Accounts payable1.58B1.74B1.84B1.79B1.44B1.64B1.88B1.77B1.10B1.03B
Current liabilities7.23B6.75B6.64B9.36B6.57B6.61B5.68B4.49B6.31B5.10B
Long-term debt4.77B5.06B4.21B1.55B3.83B4.45B4.48B5.20B1.69B3.76B
Total liabilities12.7B12.5B11.3B11.5B11.5B12.5B11.3B10.6B8.84B8.92B
Shareholders' equity11.1B11.6B9.38B10.2B10.1B9.63B7.97B7.43B6.85B6.58B
Shares outstanding977.8M944.9M948.0M964.5M1.00B1.02B1.02B1.02B1.05B

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations2.05B3.03B1.77B2.05B1.47B1.71B1.01B1.56B1.39B1.54B
Capital spending-26.7M-675.0M-59.7M-403.0M-630.2M-696.9M-845.9M-1.38B-262.9M-158.1M
Free cash flow2.03B2.36B1.82B2.04B1.26B1.71B130.3M50.2M1.11B1.39B
Cash from investing-282.3M-765.6M-663.7M-844.6M-1.37B-208.1M140.1M
Cash from financing-1.36B-1.47B189.8M-622.2M472.9M-1.69B-1.65B
Dividends paid-781.8M-778.8M-580.7M-777.7M-391.8M-391.8M-391.8M-391.8M
Share buybacks-1.88B-1.66B-1.90B-994.9M-155.8M-15.4M-90.9M-133.9M-4.01M-1.08B
Change in cash826.3M710.7M911.6M239.0M-839.0M1.18B-491.7M321.9M-753.5M30.7M

Open Financials

Cap table

Built by 6ix from Genomma Lab Internacional SAB de CV Class B’s releases

Common shares
977,752,666
Fully diluted
977,752,666

Fully diluted

LineShares
Common shares977,752,666

Share count over time

CountShares
Nov 22, 2026977,752,666

Open Cap table

Shareholders

HolderSharesValueAs of
The Hartford International Value Fund28MUS$23.8MJul 31, 2026
Fidelity Low-Priced Stock Fund13MUS$11MJul 31, 2026
Invesco Emerging Markets ex-China Fund12.7MUS$10.8MJul 31, 2026
iShares MSCI Mexico ETF10.4MUS$9.59MMay 31, 2026
iShares Core MSCI Emerging Markets ETF10.4MUS$9.55MMay 31, 2026
Vanguard Total International Stock Index Fund9.95MUS$8.44MJul 31, 2026
Vanguard Emerging Markets Stock Index Fund9.73MUS$8.25MJul 31, 2026
Cambria Emerging Shareholder Yield ETF9.58MUS$8.11MJul 31, 2026
Invesco International Small Company Fund5.43MUS$4.66MJun 30, 2026
Emerging Markets Core Equity 2 Portfolio3.23MUS$2.74MJul 31, 2026
All 48 holders
HolderSharesValueAs of
Vanguard Ftse All-World Ex-Us Small-Cap Index Fund2.78MUS$2.36MJul 31, 2026
Fidelity Low-Priced Stock K6 Fund2.5MUS$2.12MJul 31, 2026
Avantis Emerging Markets Equity ETF1.98MUS$1.82MMay 31, 2026
Dimensional Emerging Markets Value Fund1.97MUS$1.67MJul 31, 2026
WisdomTree Emerging Markets SmallCap Dividend Fund1.45MUS$1.25MJun 30, 2026
Strategic Advisers Fidelity U.S. Total Stock Fund1.27MUS$1.17MMay 31, 2026
iShares Core MSCI Total International Stock ETF917KUS$777KJul 31, 2026
The Emerging Markets Small Cap Series907KUS$769KJul 31, 2026
Dimensional Emerging Markets Core Equity 2 ETF897KUS$759KJul 31, 2026
Dimensional Emerging Core Equity Market ETF644KUS$545KJul 31, 2026
Hartford International Equity Fund573KUS$486KJul 31, 2026
Vanguard Total World Stock Index Fund533KUS$451KJul 31, 2026
College Retirement Equities Fund - Total Global Stock Account452KUS$389KJun 30, 2026
LSV Emerging Markets Equity Fund414KUS$350KJul 31, 2026
Fidelity Total International Index Fund406KUS$344KJul 31, 2026
Dimensional World ex. U.S. Core Equity 2 ETF392KUS$332KJul 31, 2026
OTG Latin America ETF384KUS$329KJun 30, 2026
State Street(R) SPDR(R) S&P(R) Emerging Markets Small Cap ETF365KUS$314KJun 30, 2026
State Street Global All Cap Equity ex-U.S. Index Portfolio263KUS$226KJun 30, 2026
Dimensional Emerging Markets Value ETF240KUS$203KJul 31, 2026
Emerging Markets Sustainability Core 1 Portfolio208KUS$176KJul 31, 2026
iShares MSCI Emerging Markets Small-Cap ETF166KUS$153KMay 31, 2026
Emerging Markets ex China Core Equity Portfolio164KUS$139KJul 31, 2026
World ex U.S. Core Equity Portfolio157KUS$133KJul 31, 2026
Parametric Tax-Managed Emerging Markets Fund144KUS$124KJun 30, 2026
Avantis Emerging Markets Equity Fund142KUS$131KMay 31, 2026
Vanguard ESG International Stock ETF142KUS$130KMay 31, 2026
Avantis Emerging Markets ex-China Equity ETF125KUS$115KMay 31, 2026
Dimensional Emerging Markets Sustainability Core 1 ETF108KUS$91,293Jul 31, 2026
Emerging Markets Targeted Value Portfolio98,024US$83,029Jul 31, 2026
Wilmington Global Alpha Equities Fund88,661US$75,098Jul 31, 2026
World ex U.S. Targeted Value Portfolio78,280US$66,305Jul 31, 2026
Parametric Emerging Markets Fund76,500US$64,797Jul 31, 2026
Dimensional Emerging Markets ex China Core Equity ETF48,800US$41,289Jul 31, 2026
SA Emerging Markets Value Fund42,530US$36,432Jun 30, 2026
Avantis Responsible Emerging Markets Equity ETF36,941US$34,007May 31, 2026
Avantis Emerging Markets Small Cap Equity ETF28,800US$26,513May 31, 2026
State Street(R) SPDR(R) S&P Emerging Markets ex-China ETF1,660US$1,428Jun 30, 2026

Open Shareholders

Log in to ask 6ix AI your own questions about Genomma Lab Internacional SAB de CV.